According to the research report titled, 'Mental-Care & Nootropic Ingredients Market Size, Share, Trends, Growth Opportunities & Forecast by Ingredient Type (Botanical Extracts/Adaptogens, Amino Acids, Vitamins & Minerals, Synthetic Nootropics), Function, Application, Distribution Channel, and Region - Global Forecast (2025 -2035)' the mental-care and nootropic ingredients market is projected to reach $12.72 billion by 2035, at a CAGR of 9.6% during the forecast period 2025-2035. The report provides an in-depth analysis of the global mental-care and nootropic ingredients market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2035.
Succeeding extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges. The growth of this market is driven by the rising prevalence of mental health disorders and stress-related conditions, increasing consumer awareness of cognitive health and preventive mental wellness, growing demand for natural and plant-based solutions, expanding clinical validation and regulatory acceptance of mental wellness claims, and the rising integration of nootropic ingredients into functional beverages and foods. Moreover, advancements in gut-brain axis research and psychobiotic innovation, functional beverage expansion and nootropic coffee alternatives, and personalized nutrition approaches for cognitive health are expected to support the market's growth.
The key players operating in the mental-care and nootropic ingredients market are Sabinsa Corporation (USA), Arjuna Natural Pvt. Ltd. (India), Ixoreal Biomed Inc. (India), Natreon Inc. (USA), Kyowa Hakko Bio Co. Ltd. (Japan), DSM-Firmenich (Switzerland), Chr. Hansen Holding A/S - Novonesis (Denmark), Glanbia Nutritionals (Ireland), Verdure Sciences (USA), Nexira (France), Nammex (Canada), and others.
The mental-care and nootropic ingredients market is segmented by ingredient type (botanical extracts/adaptogens, amino acids, vitamins and minerals, omega-3s and lipids, probiotics and microbiome-based ingredients, synthetic nootropics, and others), function (stress and anxiety relief, mood enhancement and emotional well-being, cognitive performance, neuroprotection and brain health, sleep and recovery, and energy and mental fatigue), application (dietary supplements, functional foods and beverages, personal care or nutraceutical cosmetics, pharmaceuticals for clinical mental health use, sports nutrition, and others), distribution channel (direct sales to manufacturers, distributors and ingredient brokers, online B2B platforms, and others), and geography. The study also evaluates industry competitors and analyzes the market at the country level.
Based on ingredient type, the botanical extracts and adaptogens segment held the largest share of the mental care and nootropic ingredients market in 2025. This dominance comes from the growing consumer preference for natural and plant-based options for managing stress, improving cognitive function, and enhancing emotional well-being. Scientific support for traditional adaptogenic herbs like ashwagandha, rhodiola, ginseng, and lion's mane mushroom, along with the rising popularity of Ayurvedic and traditional medicine worldwide, also fuels this segment's growth. The clean-label trend and consumer preference for botanical ingredients over synthetic ones continue to increase demand. Ashwagandha makes up a significant portion of the adaptogenic ingredients market, with India producing about 85% of the global supply from over 14,000 hectares. These botanical ingredients provide proven benefits for stress management, cognitive improvement, and emotional balance, backed by both traditional use and modern clinical research. The growth of this segment reflects a major shift in consumer attitudes toward mental wellness, favoring natural, holistic solutions over pharmaceutical options.
Regarding function, the stress and anxiety relief segment held the largest share of the mental care and nootropic ingredients market in 2025. This dominance reflects the widespread effects of chronic stress on modern populations and the growing preference for natural, non-drug options for stress management. The World Health Organization reported that the COVID-19 pandemic caused a 25% increase in anxiety and depression cases worldwide, which significantly raised consumer interest in natural mental wellness solutions. Ingredients like ashwagandha, rhodiola rosea, L-theanine, GABA, and magnesium are commonly used in this segment. Clinical studies show they can help regulate cortisol levels and support healthy stress responses. The normalization of mental health discussions, driven by public health campaigns and celebrity advocacy, has lessened the stigma around stress management products. Modern lifestyle factors such as workplace pressures, academic demands, digital overload, and constant connectivity contribute to higher stress levels in all demographics. Consumers increasingly seek ingredients that provide calm without sedation, reduce anxiety with no side effects, and support emotional resilience during tough times.
In terms of application, the dietary supplements segment accounted for the largest share of the mental care and nootropic ingredients market in 2025. This dominance comes from the established supplement industry, high consumer awareness of cognitive health benefits, and the growing preference for easy-to-use, encapsulated formats that provide accurate dosing and standardized ingredient concentrations. The global dietary supplements market reached $133.77 billion in 2024 and is projected to grow at a rate of 4.9% each year through 2032, with brain health supplements being one of the fastest-growing categories. The increasing occurrence of cognitive health issues globally, especially among older populations aiming to maintain mental sharpness and prevent age-related cognitive decline, continues to drive demand. Supplement formats offer several benefits, including concentrated ingredient doses, precise standardization, convenience, long shelf life, and the ability to combine multiple synergistic ingredients in one formulation. The segment benefits from well-established distribution networks, including pharmacies, health food stores, e-commerce platforms, and direct-to-consumer sales. Consumer trust in supplement brands, supported by third-party testing, quality certifications, and clear labeling, further boosts market growth.
For distribution channels, the direct sales to manufacturers segment held the largest share of the mental care and nootropic ingredients market in 2025. This segment’s dominance stems from the reduction of intermediary costs, the ability to provide customized ingredient solutions that meet specific manufacturer needs, and the established relationships between major ingredient suppliers and large nutraceutical and pharmaceutical companies. The direct sales model offers significant benefits in customization and technical support, with ingredient suppliers collaborating directly with manufacturers to deliver tailored solutions, including custom particle sizes, specialized extraction methods, proprietary blends, and application-specific standardization levels. This channel fosters close cooperation on product development, allowing ingredient suppliers to understand manufacturers’ needs and provide formulation support, regulatory documentation, quality assurance, and technical expertise. Major dietary supplement manufacturers, functional food producers, and pharmaceutical firms prefer direct relationships with ingredient suppliers to ensure supply chain security, maintain quality control, access technical innovation, and negotiate better pricing. The direct sales model promotes transparency throughout the supply chain, from raw material sourcing to final ingredient delivery, which is increasingly essential for manufacturers responding to clean-label requirements.
A detailed geographic analysis of the industry provides both qualitative and quantitative insights into five major regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa, alongside key countries in each region. North America commanded the largest share of the overall mental care and nootropic ingredients market in 2025. This result is tied to high consumer awareness regarding cognitive health, a strong wellness culture, the presence of major market players, supportive regulations that ease product development and market access, and high consumer spending power. The United States leads the global nootropics market, supported by a robust health and wellness sector where around 60% of adults take dietary supplements. The region's well-developed retail infrastructure includes both physical stores with dedicated nootropic sections and sophisticated e-commerce platforms, ensuring a wide range of products are available across diverse demographic groups. North America's active biohacking culture and growing interest in cognitive enhancement among students, professionals, and entrepreneurs have expanded the consumer base beyond traditional supplement users. The region also benefits from advanced research institutions, clinical trial setups, and regulatory pathways that support ingredient innovation and product development.
Succeeding extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges. The growth of this market is driven by the rising prevalence of mental health disorders and stress-related conditions, increasing consumer awareness of cognitive health and preventive mental wellness, growing demand for natural and plant-based solutions, expanding clinical validation and regulatory acceptance of mental wellness claims, and the rising integration of nootropic ingredients into functional beverages and foods. Moreover, advancements in gut-brain axis research and psychobiotic innovation, functional beverage expansion and nootropic coffee alternatives, and personalized nutrition approaches for cognitive health are expected to support the market's growth.
The key players operating in the mental-care and nootropic ingredients market are Sabinsa Corporation (USA), Arjuna Natural Pvt. Ltd. (India), Ixoreal Biomed Inc. (India), Natreon Inc. (USA), Kyowa Hakko Bio Co. Ltd. (Japan), DSM-Firmenich (Switzerland), Chr. Hansen Holding A/S - Novonesis (Denmark), Glanbia Nutritionals (Ireland), Verdure Sciences (USA), Nexira (France), Nammex (Canada), and others.
The mental-care and nootropic ingredients market is segmented by ingredient type (botanical extracts/adaptogens, amino acids, vitamins and minerals, omega-3s and lipids, probiotics and microbiome-based ingredients, synthetic nootropics, and others), function (stress and anxiety relief, mood enhancement and emotional well-being, cognitive performance, neuroprotection and brain health, sleep and recovery, and energy and mental fatigue), application (dietary supplements, functional foods and beverages, personal care or nutraceutical cosmetics, pharmaceuticals for clinical mental health use, sports nutrition, and others), distribution channel (direct sales to manufacturers, distributors and ingredient brokers, online B2B platforms, and others), and geography. The study also evaluates industry competitors and analyzes the market at the country level.
Based on ingredient type, the botanical extracts and adaptogens segment held the largest share of the mental care and nootropic ingredients market in 2025. This dominance comes from the growing consumer preference for natural and plant-based options for managing stress, improving cognitive function, and enhancing emotional well-being. Scientific support for traditional adaptogenic herbs like ashwagandha, rhodiola, ginseng, and lion's mane mushroom, along with the rising popularity of Ayurvedic and traditional medicine worldwide, also fuels this segment's growth. The clean-label trend and consumer preference for botanical ingredients over synthetic ones continue to increase demand. Ashwagandha makes up a significant portion of the adaptogenic ingredients market, with India producing about 85% of the global supply from over 14,000 hectares. These botanical ingredients provide proven benefits for stress management, cognitive improvement, and emotional balance, backed by both traditional use and modern clinical research. The growth of this segment reflects a major shift in consumer attitudes toward mental wellness, favoring natural, holistic solutions over pharmaceutical options.
Regarding function, the stress and anxiety relief segment held the largest share of the mental care and nootropic ingredients market in 2025. This dominance reflects the widespread effects of chronic stress on modern populations and the growing preference for natural, non-drug options for stress management. The World Health Organization reported that the COVID-19 pandemic caused a 25% increase in anxiety and depression cases worldwide, which significantly raised consumer interest in natural mental wellness solutions. Ingredients like ashwagandha, rhodiola rosea, L-theanine, GABA, and magnesium are commonly used in this segment. Clinical studies show they can help regulate cortisol levels and support healthy stress responses. The normalization of mental health discussions, driven by public health campaigns and celebrity advocacy, has lessened the stigma around stress management products. Modern lifestyle factors such as workplace pressures, academic demands, digital overload, and constant connectivity contribute to higher stress levels in all demographics. Consumers increasingly seek ingredients that provide calm without sedation, reduce anxiety with no side effects, and support emotional resilience during tough times.
In terms of application, the dietary supplements segment accounted for the largest share of the mental care and nootropic ingredients market in 2025. This dominance comes from the established supplement industry, high consumer awareness of cognitive health benefits, and the growing preference for easy-to-use, encapsulated formats that provide accurate dosing and standardized ingredient concentrations. The global dietary supplements market reached $133.77 billion in 2024 and is projected to grow at a rate of 4.9% each year through 2032, with brain health supplements being one of the fastest-growing categories. The increasing occurrence of cognitive health issues globally, especially among older populations aiming to maintain mental sharpness and prevent age-related cognitive decline, continues to drive demand. Supplement formats offer several benefits, including concentrated ingredient doses, precise standardization, convenience, long shelf life, and the ability to combine multiple synergistic ingredients in one formulation. The segment benefits from well-established distribution networks, including pharmacies, health food stores, e-commerce platforms, and direct-to-consumer sales. Consumer trust in supplement brands, supported by third-party testing, quality certifications, and clear labeling, further boosts market growth.
For distribution channels, the direct sales to manufacturers segment held the largest share of the mental care and nootropic ingredients market in 2025. This segment’s dominance stems from the reduction of intermediary costs, the ability to provide customized ingredient solutions that meet specific manufacturer needs, and the established relationships between major ingredient suppliers and large nutraceutical and pharmaceutical companies. The direct sales model offers significant benefits in customization and technical support, with ingredient suppliers collaborating directly with manufacturers to deliver tailored solutions, including custom particle sizes, specialized extraction methods, proprietary blends, and application-specific standardization levels. This channel fosters close cooperation on product development, allowing ingredient suppliers to understand manufacturers’ needs and provide formulation support, regulatory documentation, quality assurance, and technical expertise. Major dietary supplement manufacturers, functional food producers, and pharmaceutical firms prefer direct relationships with ingredient suppliers to ensure supply chain security, maintain quality control, access technical innovation, and negotiate better pricing. The direct sales model promotes transparency throughout the supply chain, from raw material sourcing to final ingredient delivery, which is increasingly essential for manufacturers responding to clean-label requirements.
A detailed geographic analysis of the industry provides both qualitative and quantitative insights into five major regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa, alongside key countries in each region. North America commanded the largest share of the overall mental care and nootropic ingredients market in 2025. This result is tied to high consumer awareness regarding cognitive health, a strong wellness culture, the presence of major market players, supportive regulations that ease product development and market access, and high consumer spending power. The United States leads the global nootropics market, supported by a robust health and wellness sector where around 60% of adults take dietary supplements. The region's well-developed retail infrastructure includes both physical stores with dedicated nootropic sections and sophisticated e-commerce platforms, ensuring a wide range of products are available across diverse demographic groups. North America's active biohacking culture and growing interest in cognitive enhancement among students, professionals, and entrepreneurs have expanded the consumer base beyond traditional supplement users. The region also benefits from advanced research institutions, clinical trial setups, and regulatory pathways that support ingredient innovation and product development.
Key Questions Answered in the Report:
- What is the current revenue generated by the mental-care and nootropic ingredients market globally?
- At what rate is the global mental-care and nootropic ingredients demand projected to grow for the next 5-10 years?
- What are the historical market sizes and growth rates of the global mental-care and nootropic ingredients market?
- What are the major factors impacting the growth of this market at the regional and country levels? What are the major opportunities for existing players and new entrants in the market?
- Which segments in terms of ingredient type, function, application, and distribution channel are expected to create major traction for the manufacturers in this market?
- What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the manufacturers operating in the global mental-care and nootropic ingredients market?
- Who are the major players in the global mental-care and nootropic ingredients market? What are their specific product offerings in this market?
- What are the recent strategic developments in the global mental-care and nootropic ingredients market? What are the impacts of these strategic developments on the market?
Scope of the Report:
Mental-Care & Nootropic Ingredients Market Assessment - by Ingredient Type
- Botanical Extracts/Adaptogens
- Amino Acids
- Vitamins & Minerals
- Omega-3s and Lipids
- Probiotics and Microbiome-Based Ingredients
- Synthetic Nootropics
- Others
Mental-Care & Nootropic Ingredients Market Assessment - by Function
- Stress and Anxiety Relief
- Mood Enhancement and Emotional Well-being
- Cognitive Performance (Memory, Focus, Learning)
- Neuroprotection and Brain Health
- Sleep and Recovery
- Energy & Mental Fatigue
Mental-Care & Nootropic Ingredients Market Assessment - by Application
- Dietary Supplements
- Functional Foods and Beverages
- Personal Care/Nutraceutical Cosmetics
- Pharmaceuticals for Clinical Mental Health Use
- Sports Nutrition
- Others
Mental-Care & Nootropic Ingredients Market Assessment - by Distribution Channel
- Direct Sales to Manufacturers
- Distributors and Ingredient Brokers
- Online B2B Platforms
- Others
Mental-Care & Nootropic Ingredients Market Assessment - by Geography
North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Middle East & Africa
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Table of Contents
1 Introduction
2 Research Methodology
4 Market Insights
5 The Impact of Ingredient Innovation and Technology on The Global Mental-Care & Nootropic Ingredients Market
6 Global Mental-Care & Nootropic Ingredients Market, By Ingredient Type
7 Global Mental-Care & Nootropic Ingredients Market, By Function
8 Global Mental-Care & Nootropic Ingredients Market, By Application
9 Global Mental-Care & Nootropic Ingredients Market, By Distribution Channel
10 Mental-Care & Nootropic Ingredients Market Assessment, By Geography
11 Competitive Landscape
12 Company Profiles
13 Appendix
Companies Mentioned
- Sabinsa Corporation
- Arjuna Natural Pvt. Ltd.
- Ixoreal Biomed Inc.
- Natreon Inc.
- Kyowa Hakko Bio Co. Ltd.
- DSM-Firmenich
- Chr. Hansen Holding A/S - Novonesis
- Glanbia Nutritionals
- Verdure Sciences
- Nexira
- Nammex
